Resultados de la búsqueda
Marathe K, Marwood OEG, Ahmad M. Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment. Europace (2022) 24:698-699
Mazzanti A, Trancuccio A, Priori SG. Programmed electrophysiological stimulation for risk prediction in patients with Brugada syndrome: closing time? Rev Esp Cardiol (2022) 75:545-548
Mazzanti A, Kukavica D, Trancuccio A, Memmi M, Bloise R, Gambelli P, Marino M, Ortíz-Genga M, Morini M, Monteforte N, Giordano U, Keegan R, Tomasi L, Anastasakis A, Davis AM, Shimizu W, Blom NA, Santiago DJ, Napolitano C, Monserrat L, Priori SG. Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers. JAMA Cardiol (2022) 7:504-512
Wang M, Peterson DR, Pagan E, Bagnardi V, Mazzanti A, McNitt S, Rich DQ, Seplaki CL, Kutyifa V, Polonsky B, Barsheshet A, Kukavica D, Rosero S, Goldenberg I, Priori S, Zareba W. Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients Front Cardiovasc Med (2022) 9
Link to the full text in Repisalud
Link to the full text in Repisalud
Kukavica D, Trancuccio A, Arnò C, Latini AC, Mazzanti A, Priori SG. Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? Minerva Cardiol Angiol (2022) 70:217-237
Priori SG, Mazzanti A. Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia-Reply Response. JAMA Cardiol (2022) 7:1175-+
Priori SG, Mazzanti A, Santiago DJ, Kukavica D, Trancuccio A, Kovacic JC Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 J Am Coll Cardiol (2021) 77:2592-2612
Bhaskaran A, Niri A, Azam MA, Nayyar S, Porta-Sánchez A, Massé S, Liang T, Veluppillai A, Du B, Lai PFH, Ha A, Nanthakumar K Safety, efficacy, and monitoring of bipolar radiofrequency ablation in beating myopathic human and healthy swine hearts Heart Rhythm (2021) 18:1772-1779
Jøns C, Porta-Sánchez A, Lai PFH, Wauchop M, Massé S, Azam MA, Asta J, Rose RA, Nanthakumar K Mechanism of and strategy to mitigate liraglutide-mediated positive chronotropy Life Sci (2021) 282:119815
Sun B, Yao J, Ni M, Wei J, Zhong X, Guo W, Zhang L, Wang R, Belke D, Chen YX, Lieve KVV, Broendberg AK, Roston TM, Blankoff I, Kammeraad JA, von Alvensleben JC, Lazarte J, Vallmitjana A, Bohne LJ, Rose RA, Benitez R, Hove-Madsen L, Napolitano C, Hegele RA, Fill M, Sanatani S, Wilde AAM, Roberts JD, Priori SG, Jensen HK, Chen SRW Cardiac ryanodine receptor calcium release deficiency syndrome Sci Transl Med (2021) 13:eaba7287